RKDA (STOCKS)
Arcadia Biosciences, Inc.
$1.321600
+0.001600 (+0.12%)
Prev close: $1.320000
Company Information
- Exchange
- XNAS
- Sector
- Process Industries
- Industry
- Chemicals: Agricultural
- CEO
- Thomas J. Schaefer
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2.73M
- Employees
- 9
- P/E (TTM)
- -0.77
- P/B (TTM)
- 0.44
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$0.62 | $-0.55 | +1.1708 | +212.56% |
|
Jun 2025 (Q2)
|
$0.02 | $-0.81 | +0.8258 | +102.48% |
|
Mar 2025 (Q1)
|
$1.90 | $-1.00 | +2.8996 | +290.08% |
|
Dec 2024 (Q4)
|
$-2.99 | $-0.91 | -2.0822 | -229.37% |
Financial Statements
| Revenues | $4.86M |
| Benefits Costs and Expenses | $7.19M |
| Cost Of Revenue | $3.10M |
| Costs And Expenses | $7.36M |
| Gross Profit | $1.76M |
| Operating Expenses | $4.26M |
| Selling, General, and Administrative Expenses | $7.00M |
| Research and Development | $9.00K |
| Operating Income/Loss | -$2.50M |
| Income/Loss From Continuing Operations After Tax | -$2.34M |
| Income/Loss From Continuing Operations Before Tax | -$2.33M |
| Income Tax Expense/Benefit | $8.00K |
| Income Tax Expense/Benefit, Current | $8.00K |
| Income Tax Expense/Benefit, Deferred | $0.00 |
| Interest Income/Expense After Provision For Losses | $221.00K |
| Interest Income/Expense Operating, Net | $221.00K |
| Net Income/Loss | -$2.34M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$2.34M |
| Net Income/Loss Available To Common Stockholders, Basic | -$2.34M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | $0.00 |
| Basic Earnings Per Share | -$1.71 |
| Diluted Earnings Per Share | -$1.71 |
| Basic Average Shares | 1,368,057 |
| Diluted Average Shares | 1,368,057 |
| Assets | $6.55M |
| Current Assets | $6.36M |
| Inventory | $1.21M |
| Other Current Assets | $5.14M |
| Noncurrent Assets | $190.00K |
| Fixed Assets | $8.00K |
| Intangible Assets | $39.00K |
| Other Non-current Assets | $143.00K |
| Liabilities | $2.41M |
| Current Liabilities | $2.06M |
| Wages | $107.00K |
| Other Current Liabilities | $1.95M |
| Noncurrent Liabilities | $347.00K |
| Equity | $4.14M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $4.14M |
| Liabilities And Equity | $6.55M |
| Net Cash Flow From Operating Activities | -$4.74M |
| Net Cash Flow From Operating Activities, Continuing | -$4.74M |
| Net Cash Flow From Investing Activities | $750.00K |
| Net Cash Flow From Investing Activities, Continuing | $750.00K |
| Net Cash Flow From Financing Activities | $6.00K |
| Net Cash Flow From Financing Activities, Continuing | $6.00K |
| Net Cash Flow | -$3.98M |
| Net Cash Flow, Continuing | -$3.98M |
| Comprehensive Income/Loss | -$2.34M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$2.34M |
| Other Comprehensive Income/Loss | $0.00 |